You can now watch our webinar on “New Guidelines for the Management of Heart Valve Disease: Implications for Interventional Cardiology”, held via Zoom on...
Following the presentation of the NEO-MINDSET study in the Late Breaking Clinical Trials sessions at the European Society of Cardiology Congress (ESC 2025), Dr....
The third and final day of the SOLACI-SOCIME 2025 Congress concluded with a high-impact scientific agenda, featuring joint sessions with prestigious international institutions and...
Tricuspid regurgitation (TR) is a condition whose prevalence is expected to increase in the coming years. Surgery presents important challenges and is associated with...
Several randomized clinical trials have demonstrated the superiority of coronary artery bypass grafting (CABG) over percutaneous coronary intervention (PCI) in patients with left main...
Mitral regurgitation (MR) is a common valve disease associated with heart failure, hospitalizations, and mortality.
In women, it is often overlooked and some analyses have...
